*Nicholas Livingston1, Amanda Kiemes1, Gabriel A Devenyi3, Samuel Knight1, Paulina Lukow1, Luke Jelen1, Thomas Reilly2, Aikaterini Dima1, Maria Antonietta Nettis1, Cecilia Casetta1, Tyler Agyekum3, Fernando Zelaya1, Thomas Spencer1, Paolo Fusar-Poli1, Steven CR Williams1, Philip McGuire2, Alice Egerton1, Mallar M Chakravarty3, Gemma Modinos1 (1. Institute of Psychiatry, Psychology, and Neuroscience, King's College London, 2. University of Oxford, Oxford, 3. Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University)
Session information
[CINP2024] Short Communications
CINP2024 » Short Communications
Short Communications 27
Schizophrenia 3 - Clinical (3)
Sun. May 26, 2024 2:50 PM - 3:40 PM Room 8 (G405)
Chair: Hidenori Yamasue (Hamamatsu University School of Medicine)
*CHUN-I LIU1, Ko Yen1, Chen-Chung Liu1,2 (1. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan, 2. Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan)
*Chin B Eap1, Setareh Ranjbar2, Franziska Gamma3, Kerstin von Plessen4, Armin von Gunten5, Philippe Conus6, Cecile Gras1, Marianna Piras1 (1. Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Hospital of Cery, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, 2. Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 3. Les Toises Psychiatry and Psychotherapy Center, Lausanne, Switzerland, 4. Service of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 5. Service of Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 6. Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.)
*Atheeshaan Arumuham1,2,3,4, Yuya Mizuno1,4,5, Oisin O'Brien1,6, Maria Lobo4, Sita Parmar4, Luke Baxter4, Stephen Jolles7, Oliver D Howes1,2,3,4,8 (1. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, De Crespigny Park, London, SE5 8AF, UK, 2. Psychiatric Imaging Group, Medical Research Council, London Institute of Medical Sciences, Hammersmith Hospital, London W12 0NN, UK, 3. Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK, 4. South London and Maudsley NHS Foundation Trust, London, UK, 5. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 6. Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland, 7. Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK, 8. H Lundbeck A/s, 3 Abbey View, Everard Close, St Albans, AL1 2PS, UK)